Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. announced that the AmoyDx® Pan Lung Cancer PCR Panel, an in vitro diagnostic reagent developed as a companion diagnostic for multiple anti-cancer agents, was approved by Ministry of Health, Labour and Welfare for production and marketing in Japan on June 25, 2021.
June 30, 2021
· 4 min read